GeneralConnection.com ➔ Dictionary
Dictionary Search

savara

Synonyms

Noun

1. Savara

2. Dravidian, Savara

3. South-Central Dravidian

Usage
Savara Announces New Employment Inducement Grant - Business Wire
Savara (SVRA) Stock Valuation After CFO Transition And Leadership Change - simplywall.st
Savara Inc. (SVRA) Reports Q1 Financial Results - Yahoo Finance
Savara: The Rare Disease Funnel Is Becoming A Commercial Asset (NASDAQ:SVRA) - Seeking Alpha
FDA delays decision on Savara’s rare lung disease therapy to November - FirstWord Pharma
Savara (SVRA) expands share capacity and appoints Robert Lutz as CFO/COO - Stock Titan
FDA Extends Review of Savara’s Molgramostim BLA for PAP - BioPharm International
Savara shareholders approve share increases and executive changes at annual meeting - Investing.com
How Investors Are Reacting To Savara (SVRA) Doubling Share Authorization And Reshaping Its CFO Role - simplywall.st
Savara Announces Chief Financial and Administrative Officer Transition - Business Wire
Assessing Savara (SVRA) Valuation As Shares Cool After Strong Long Term Returns - Yahoo Finance
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference - Business Wire
Savara (SVRA) Is Down 8.0% After FDA Grants Priority Review To MOLBREEVI - What's Changed - Yahoo Finance
Assessing Savara (SVRA) Valuation As A High Price To Book Meets Strong One Year Shareholder Returns - simplywall.st
Assessing Savara (SVRA) Valuation After FDA Extends Priority Review For Molgramostim - Yahoo Finance
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Business Wire
Savara Announces Participation in 2026 Citizens Life Sciences Conference - Business Wire
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI* - Yahoo Finance
Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update - Business Wire
Savara To Present New Data at the American Thoracic Society (ATS) 2026 International Conference - Business Wire
Savara Provides Regulatory Update on the MOLBREEVI* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Yahoo Finance
Savara Highlights FDA Priority Review for Molbreevi as Aug. 22 PDUFA Date Nears - Yahoo Finance
Savara upgraded at H.C. Wainwright on potential refiling of marketing application - MSN
Savara: Lowrance Will Remain Available in Advisory Capacity >SVRA - Moomoo
Savara Eyes August PDUFA for MOLBREEVI as FDA BLA Filing Decision Nears, Execs Say at Summit - Yahoo Finance
Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Yahoo Finance
Savara Announces Chief Financial And Administrative Officer Transition - TradingView
Savara Is On Xbox And PlayStation – And It Wants You To Earn Every Victory - TheXboxHub
A Look At Hercules Capital (HTGC) Valuation After The Expanded Savara Loan Agreement - Yahoo Finance
Action Roguelite Savara Released on Consoles - RPGamer
Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 20 - Yahoo Finance
Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Yahoo Finance
Savara, the colorful action roguelite launches Today on PlayStation 5 and Xbox Series X|S - Games Press
SVRA News | SAVARA INC (NASDAQ:SVRA) - ChartMill
Savara Announces Participation in Upcoming Investor Healthcare Conferences - Business Wire
Savara’s FDA Review Extension Keeps Molgramostim Thesis Intact But Delayed - simplywall.st
New aPAP Phase 3 Data and Wider Losses Might Change The Case For Investing In Savara (SVRA) - simplywall.st
Savara Inc. Announces CFO Changes - marketscreener.com
Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Savara (SVRA) Announces Leadership Changes in Finance Department - GuruFocus
What Does Wall Street Think About Savara Inc. (SVRA)? - Yahoo Finance
Roguelite action game Savara coming to PS5, Xbox Series on May 20 - Gematsu
Jefferies sees Savara stock approval odds at 90% for rare lung drug - Investing.com
Savara Reports First Quarter Financial Results and Provides Business Update - Business Wire
Citizens reiterates Savara stock rating on likely FDA approval - Investing.com
Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants - Business Wire
Savara Inc. Announces Step Down of Dave Lowrance as Chief Administrative Officer, Effective July 15, 2026 - marketscreener.com
Savara Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $149.5M - Business Wire
Wells Fargo Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Savara gives 24 new hires stock awards tied to tenure and revenue - Stock Titan
Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Business Wire
Savara Stock: A High-Risk Opportunity (NASDAQ:SVRA) - Seeking Alpha
Savara Reports First Quarter Financial Results and Provides Business Update - BioSpace
Savara Has Finally Arrived on PlayStation 5 and Xbox Series X/S Today - COGconnected
FDA extends review of Savara’s molgramostim application - Investing.com
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System - BioSpace
Savara CFO Dave Lowrance to step down, Robert Lutz to expand role By Investing.com - Investing.com South Africa
Savara (SVRA) deepens Q1 2026 loss while pushing MOLBREEVI toward key FDA and EMA decisions - Stock Titan
Savara announced that its Chief Financial and Administrative Officer, Dave Lowrance, will officially step down on July 15, 2026. - Bitget
Savara Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView
Savara CFO Dave Lowrance steps down; COO Robert Lutz takes on CFO role amid leadership reshuffle - Pluang
Savara shareholders approve share increases and executive changes at annual meeting - Investing.com Nigeria
Savara Review (PS5) – Savara’Faire - fingerguns.net
What Does the FDA's Priority Review Mean for Savara's MOLBREEVI - Kavout
Citizens reiterates Savara stock rating on regulatory progress - Investing.com
Savara CFO to step down - MSN
LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Raises Target Price to $10 - Moomoo
Savara - Launch Trailer (PS5) - Gamereactor UK
Action Roguelite Savara Launches On PlayStation 5 And Xbox Series X|S - The Otaku's Study
Savara CFO to step down - MSN
Savara receives European patent for PAP treatment device - Investing.com
Savara - Official Launch Trailer - IGN India
Savara secures additional $75m in debt financing for potential drug launch - Investing.com
Savara Combines Roguelite Progression And Soulslike Combat In A Colorful Fantasy World - Yahoo Tech
Langhorne, PA Biotech Eyes Mid-2026 Molbreevi Launch - Streetwise Reports
EMA validates Savara’s MOLBREEVI application for autoimmune PAP - Investing.com
SVRA: All proposals, including director elections and plan amendments, were approved - TradingView
H.C. Wainwright reiterates Savara stock rating, $10 target - Investing.com
Savara Inc. Confirms Participation in 2026 Citizens Life Sciences Conference Focused on Rare Respiratory Diseases - geneonline.com
Dumper rams BJP MP Hemant Savara’s car near Mumbai; driver suffers fracture - The Times of India
Savara faces earnings test ahead of crucial FDA decision By Investing.com - Investing.com South Africa
Savara gets FDA review extension for lead asset - MSN
Class Action Lawsuit Filed Against Savara Inc. (SVRA) - Recover Losses - Contact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire
Levi & Korsinsky Notifies Savara Inc. (SVRA) Shareholders of Class Action Lawsuit and November 7, 2025 Deadline - ACCESS Newswire
Savara reports exercise improvements in aPAP drug trial By Investing.com - Investing.com Australia
Savara steps into Grammy spotlight with consideration in two categories - Citizen Digital
Class Action Alert: Levi & Korsinsky Reminds Savara Inc. (SVRA) Investors of November 7, 2025 Deadline - ACCESS Newswire
FDA calls for additional manufacturing data in refusal letter for Savara's respiratory asset - Fierce Pharma
Savara Inc stock (US80633A1025): respiratory disease specialist after latest clinical and funding up - AD HOC NEWS
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital - Business Wire
Tribals fight to protect lands from encroachment in Andhra's Srikakulam - The New Indian Express
Savara Inc stock (US80633A1025): fresh IMPALA?2 data at ATS 2026 keeps rare?disease bet in focus - AD HOC NEWS
Savara Inc stock (US80633A1025): Jefferies conference appearance keeps rare-disease biotech in focus - AD HOC NEWS
CHAN Final to attract star-studded music line-up including Eddy Kenzo, Zuchu and Savara at TotalEnergies CHAN, PAMOJA 2024, Closing Ceremony - Confédération Africaine de Football
Kenya’s Savara Earns Grammy Consideration for Chart-Topping Tracks - KenyanVibe
Manufacturing issues scupper Savara's lead drug filing - pharmaphorum
Evercore Downgrades Savara on Manufacturing Concerns for Lung Disease Drug Candidate - Yahoo Finance
Forest Rights Without Women's Rights: How FRA Delays Shape Tribal Women's Lives In Srikakulam - Feminism in India
symbol__ Stock Quote Price and Forecast - CNN
SVRA stock slips post-market after FDA delays decision on pulmonary therapy - MSN
Foreign Language Equivalents
Foreign Language Equivalents of 'savara'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
savraa,   savaara,   savsra,   aavara,   sacara,   savar,   avara,   davara,   savarra,   savaa,   svara,   ssvara,   savata,   savaraa,   saavra,   savvara,   ssavara,   saavara,   savra,   savaar,   savaea,   savars,   saara,   asvara,   svaara,   sabara
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z